Megaforce Co. Ltd. · TPEX:3294

Megaforce — Investor Presentation (December 2024)

22 slides from Megaforce's investor presentation, Dec 24, 2024

  1. Slide 1: Megaforce Company Limited 2024 Investor Conference

    Megaforce Company Limited (Stock code:3294) 2024 Investor Conference December 24,2024

  2. Slide 2: Legal Disclaimer

    Legal Disclaimer  The information contained in this presentation, including all forward-looking information, is subject to change without notice, whether as a result of new information, further events or otherwise, and Megaforce (the“Company”) undertakes no obligation to publicly update or revise t

  3. Slide 3: Outline

    Outline Company Profile • Overview • Global Operation • Business Achievements and Outlook • Plastic Components • AI Application Development • Biomedicine & System Integration Operating Performance • Consolidated Income statement • Operating Revenue and Gross Profit • Proportion of Revenue 2

  4. Slide 4: About Megaforce

    About Megaforce Established:Oct., 1991 IPO:Listed on TPEx, 2007 (stock symbol : 3294) Capital :NTD$1.32 billion Annual Revenue:NTD$ 4.14billion(2023) Employees:3,073 ( 2024/11/30) 3

  5. Slide 5: Global Operation

    Global Operation Ghai/Suzhou/Dongguan ME RCE COMPANY LIMITED Megaforce

  6. Slide 6: Business

    Business • 〝Megaforce〞is a professional plastic components manufacturer and machine optoelectronic integration service provider, with 40 years of experience and technology, Provide customers and strategic partners with more complete manufacturing solutions. • Using our strengths in resource integrat

  7. Slide 7: Achievements and Outlook

    Achievements and Outlook @ 4, MEGAFORCE COMPANY LIMITED yw. megaforce.com.tw Megaforce — www.megafo

  8. Slide 8: Megaforce Upgrade and Transformation

    Megaforce Upgrade and Transformation Technology Deployment • AI Technology in Operations Resource Optimization Explore applications in Business Model Innovation development, manufacturing, and East China Integration quality control. Propose action Process, production line, and product plans. Non-Con

  9. Slide 9: Plastic Components

    Plastic Components Technological upgrading、 Smart Manufacturing and Management  Launched the smart automated mold production line upgrade plan.  Upgrade automation in each factory area and introduce intelligent production and management systems. Use visual modules to control production schedules a

  10. Slide 10: Plastic Components

    Plastic Components Greater China Integration、 Plant relocation and upgrading plan  Lean transformation of Greater China organizations to enhance innovation and expand markets.  Integrating ASEAN market development for regional trade cooperation.  Upgrading operations for efficiency and competitiv

  11. Slide 11: AI Application Development

    AI Application Development Artificial Intelligence and Comprehensive Integration  AI Meeting Assistant:Meeting history record and recap 、 Real time voice transcription 、Handwriting recognition 、Image recognition 、Meeting summary 、Action items follow up  AI Solution for Company :Department level /

  12. Slide 12: AI Application Development

    AI Application Development Intelligent Medical Application Medical service support Health data management • Summary medical record of clinic • suggestions for registration • Integrate mobile devices for treatment (Life Log) Authoritative Wearable • subjects Medical Q&A • Provide health risk warnings

  13. Slide 13: BioMedical and System Integration

    BioMedical and System Integration Development of medical devices with system integration We offer the services across all stages of product lifecycle management:  Product Design and Prototyping Minimally Surgical  Batch Production and Product Release Instruments  Regulatory Affairs and Quality En

  14. Slide 14: BioMedical and System Integration

    BioMedical and System Integration Fortis Biosolutions strives to become a premier provider of Drug-Device Combination Products, empowers patients in managing their medication regimens anytime, anywhere.  Nasal Product Development  High Barrier device development  Aerosol platform total solution p

  15. Slide 15: Operating Performance

    Operating Performance @ 4, MEGAFORCE COMPANY LIMITED yw. megaforce.com.tw Megaforce — www.megafo

  16. Slide 16: Consolidated Income Statement

    Consolidated Income Statement Unit:NT$ T 2024 3QYTD 2023 Item Amount % Amount % Operating Revenue 3,236,337 100% 4,138,158 100% Operating costs 2,733,894 84% 3,580,213 87% Gross profit from 502,443 16% 557,945 13% operations Operating expenses 509,441 16% 604,397 14% Non-operating income and 92,668

  17. Slide 17: Revenue - Consolidated

    Revenue - Consolidated Unit:NT$ T 1,400,000 1,200,000 1,000,000 800,000 2024 Oct. & Nov. 600,000 400,000 200,000 - Q1 Q2 Q3 Q4 2023 831,250 871,092 1,309,604 1,126,212 2024 996,894 1,031,016 1,208,427 677,314 16

  18. Slide 18: GM Trend - Consolidated

    GM Trend - Consolidated Unit:NT$ T 250,000 17.14% 17.00% 18.00% 16.20% 16.31% 16.00% 200,000 12.93% 14.00% 12.78% 12.00% 150,000 10.00% 8.00% 100,000 4.77% 6.00% 50,000 4.00% 2.00% 0 0.00% 2023Q1 2023Q2 2023Q3 2023Q4 2024Q1 2024Q2 2024Q3 GM GM% 17

  19. Slide 19: Revenue proportion by Division

    Revenue proportion by Division Unit:NT$ T Total revenue 3,913,652 Total revenue 4,138,158 18

  20. Slide 20: Revenue proportion by Products

    Revenue proportion by Products Unit:NT$ T Total revenue 4,138,158 19

  21. Slide 21: Megaforce Company Limited

    2 5 MEGAFORCE COMPANY LIMITED Megaforce — wwn.megaforce.com.tw

  22. Slide 22: Thank You

    THANK YOU 2 - MEGAFORCE COMPANY LIMITED Megaforce — wwn.megaforce.com.tw

Megaforce Company — Investor Presentation (December 2024) on 6ix